Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC.

(DXCM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Dexcom : Announces Upcoming Conference Presentation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/08/2019 | 09:02am EST

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:

  • Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Stephens Nashville Investors Conference in Nashville, TN on Wednesday, November 13, 2019 at 9:45 AM (CT). The presentation, which will occur live at the Omni Nashville Hotel, will be concurrently webcast.

The link to the webcast will be available on the Dexcom IR website at investors.dexcom.com by navigating to “Events and Presentations.”

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for use by people with diabetes and by healthcare providers.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DEXCOM, INC.
01/21DEXCOM SCHEDULES FOURTH QUARTER AND : 30 p.m. Eastern Time
BU
01/13DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
AQ
01/13DEXCOM : Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter an..
BU
01/06DEXCOM : to Present at 38th Annual J.P. Morgan Healthcare Conference
BU
2019ELI LILLY AND COMPANY : - Lilly to Integrate Dexcom CGM into Personalized Diabet..
AQ
2019ELI LILLY AND : to Use Dexcom's Continuous Glucose Monitoring Devices
DJ
2019DEXCOM : Lilly to Integrate Dexcom CGM into Personalized Diabetes Management Sys..
PR
2019DEXCOM : Announces Upcoming Conference Presentation
BU
2019DEXCOM : Announces Upcoming Conference Presentation
BU
2019DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
More news
Financials (USD)
Sales 2019 1 465 M
EBIT 2019 133 M
Net income 2019 64,9 M
Debt 2019 136 M
Yield 2019 -
P/E ratio 2019 317x
P/E ratio 2020 143x
EV / Sales2019 14,8x
EV / Sales2020 12,2x
Capitalization 21 564 M
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Average target price 239,41  $
Last Close Price 235,60  $
Spread / Highest target 9,51%
Spread / Average Target 1,62%
Spread / Lowest Target -32,9%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Quentin S. Blackford Chief Operating & Financial Officer
Andrew K. Balo EVP-Clinical, Regulatory Affairs & Quality
Jacob Leach Chief Technology Officer
Jay S. Skyler Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.7.71%21 564
MEDTRONIC PLC6.73%162 145
BAXTER INTERNATIONAL INC.8.95%46 512
HOYA CORPORATION7.36%37 928
ZIMMER BIOMET HOLDINGS-0.11%30 752
TERUMO CORPORATION5.16%27 086